Reclast | Drug Injury Watch

Fosamax Femur Fractures: Many Impending Cases Go Unrecognized By Doctors And Radiologists Due To Subtle Characteristics

June 22, 2012

New 2012 Medical Journal Article By North Carolina Orthopedic Surgeon Presents Series Of Femoral Stress Fractures In Patients Using Fosamax Or Other Bisphosphonates (Posted by Tom Lamb at DrugInjuryWatch.com) William G. Ward, M.D. —…

Risk Of Femur Fractures From Osteoporosis Drugs Fosamax, Boniva, Actonel, And Reclast Related To Number Of Years Used

May 22, 2012

Using These Bisphosphonates More Than Three (3) To Five (5) Years May Not Only Increase Side Effect Risk But There May Be No Benefit To Most Patients (Posted by Tom Lamb at DrugInjuryWatch.com) In…

Reclast “Dear Doctor” Letter For Kidney Problems Should Be Sent By Novartis In U.S.

April 11, 2011

Public Citizen March 2011 Letter To FDA Points To Aclasta Safety Alert Material Sent In Canada During October 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: On September 1, 2011 the FDA announced…

Thigh Bone Leg Fractures In Older Women Using Fosamax, Boniva, Or Reclast For Five Years Or More

February 23, 2011

Long-Term Bisphosphonate Use Linked To Subtrochanteric And Femoral Shaft Fractures, Also Called Femur Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) An article published in the February 23, 2011 edition of the medical journal JAMA (Journal…

Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure

October 25, 2010

Novartis Sends "Dear Doctor" Letter To Canadian Physicians With Health Canada Endorsed Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In 2007 Aclasta (zoledronic acid 5mg) was approved by the FDA under the brand name Aclasta®…

Fosamax Femur Fracture Warning Label Change By Merck Seems Likely After Task Force Report

September 16, 2010

FDA Considering Issue Due To September 2010 American Society of Bone And Mineral Research Report About Bisphosphonate Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Drug Safety Communication: Safety update for…

Tag: Reclast

Fosamax Femur Fractures: Many Impending Cases Go Unrecognized By Doctors And Radiologists Due To Subtle Characteristics

Risk Of Femur Fractures From Osteoporosis Drugs Fosamax, Boniva, Actonel, And Reclast Related To Number Of Years Used

Reclast “Dear Doctor” Letter For Kidney Problems Should Be Sent By Novartis In U.S.

Thigh Bone Leg Fractures In Older Women Using Fosamax, Boniva, Or Reclast For Five Years Or More

Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure

Fosamax Femur Fracture Warning Label Change By Merck Seems Likely After Task Force Report